Long-term outcomes of 217 botulism cases in the Republic of Georgia
- PMID: 17578775
- DOI: 10.1086/518890
Long-term outcomes of 217 botulism cases in the Republic of Georgia
Abstract
Background: The acute paralytic syndrome of botulism has been well-described; however, little is known about its long-term consequences.
Methods: We conducted a case-control study in the Republic of Georgia to evaluate the health of patients > or =6 months after they had experienced an episode of botulism. Case patients were selected on the basis of who had had a clinical diagnosis of foodborne botulism reported to the national surveillance system from 1998 through 2003. Three control subjects were randomly selected from each patient's community.
Results: We located 217 patients who had had botulism from surveillance records, with a median time since onset of illness of 4.3 years. The median age was 37 years, and 49% of the patients were female, similar to the control subjects. Most of the patients (68%) had acquired botulism from home-conserved vegetables (probably containing toxin type B), 15% had been hospitalized for >1 month, and 25% had required mechanical ventilation. Six patients died. Of the remaining 211 patients, 68% reported having worse health at the time of the interview than 6 years before the interview, compared with 17% of 656 control subjects (matched odds ratio, 17.6; 95% confidence interval, 10.9-28.4). Overall, 49% of the patients reported their current health as "fair" or "poor," versus 25% of the control subjects (odds ratio, 5.0; 95% confidence interval, 3.2-7.6). Patients were more likely than control subjects to report fatigue, weakness, dizziness, dry mouth, and difficulty lifting objects (P<.05, for each). Patients were more likely than control subjects to report difficulty breathing caused by moderate exertion (P<.001) but not by minimal exertion or at rest. Patients were also more likely to report being limited in vigorous activities, walking 3 blocks, and climbing 3 flights of stairs (P<.05, for each). Finally, patients reported feeling significantly worse than control subjects for 6 of 11 questions regarding psychosocial well-being (P<.05, for each). In a multivariable model involving patients who had had botulism, mechanical ventilation during acute illness, older age, and region of residence independently predicted worse health.
Conclusions: Several years after acute botulism, patients reported significant health, functional, and psychosocial limitations that are likely to be consequences of the illness.
Similar articles
-
Signs and symptoms predictive of death in patients with foodborne botulism--Republic of Georgia, 1980-2002.Clin Infect Dis. 2004 Aug 1;39(3):357-62. doi: 10.1086/422318. Epub 2004 Jul 19. Clin Infect Dis. 2004. PMID: 15307002
-
Adult botulism type F in the United States, 1981-2002.Neurology. 2005 Dec 13;65(11):1694-700. doi: 10.1212/01.wnl.0000187127.92446.4c. Neurology. 2005. PMID: 16344510
-
Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen.Clin Gastroenterol Hepatol. 2007 Apr;5(4):457-60. doi: 10.1016/j.cgh.2006.11.025. Epub 2007 Feb 6. Clin Gastroenterol Hepatol. 2007. PMID: 17289440
-
Nine cases of foodborne botulism type B in France and literature review.Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):749-52. doi: 10.1007/s10096-003-1019-y. Epub 2003 Nov 6. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14605938 Review.
-
[Epidemic of type B botulism: Sion, December 1993-January 1994].Schweiz Med Wochenschr. 1995 Sep 30;125(39):1805-12. Schweiz Med Wochenschr. 1995. PMID: 7481637 Review. French.
Cited by
-
Quantitative autonomic testing in the management of botulism.J Neurol. 2009 May;256(5):803-9. doi: 10.1007/s00415-009-5022-9. Epub 2009 Feb 25. J Neurol. 2009. PMID: 19240955
-
BOTOX injection to treat strabismus after infant botulism type B infection.Am J Ophthalmol Case Rep. 2020 Aug 28;20:100895. doi: 10.1016/j.ajoc.2020.100895. eCollection 2020 Dec. Am J Ophthalmol Case Rep. 2020. PMID: 32923741 Free PMC article.
-
Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.Mol Med. 2022 Jun 3;28(1):61. doi: 10.1186/s10020-022-00487-4. Mol Med. 2022. PMID: 35659174 Free PMC article.
-
Symptomatic treatment of botulism with a clinically approved small molecule.JCI Insight. 2020 Jan 30;5(2):e132891. doi: 10.1172/jci.insight.132891. JCI Insight. 2020. PMID: 31996484 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical